Research and Markets: Global Biomarker and Companion Diagnostics Outsourcing Market

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/bfhs8p/global_biomarker) has announced the addition of the "Global Biomarker and Companion Diagnostics Outsourcing Market" report to their offering.

In order to reduce R&D failure rate, improve R&D productivity, and increase R&D investment return, drug companies now increasingly focus on the targeted therapy. Their efforts are leading to the gradual realization of personalized medicines. What drive the development and realization of personalized medicine are, however, the technologies developed in molecular biomarker and companion diagnostics (CDx). Today growing numbers of drug companies incorporate biomarkers and CDx into increasing numbers of their R&D programs.

On the other hand, discovery of biomarkers and development of CDx primarily rely on genomics and proteomics and their related technologies including metabolomics, bioinformatics, and molecule imaging, etc. Besides, drug companies are also placing more effort to completely understand the biology and genetic pathway of a disease. Genomics and proteomics research has thus been increasingly integrated into drug company's discovery and development programs. These technologies play increasingly important roles in the modern pharmaceutical and healthcare industries.

However, at present most drug companies, including those major ones, still have not gained sufficiently strong in-house capabilities and capacities in these areas. They therefore need supports/services from external organizations. The service demands for genomics/proteomics research, biomarker discovery, and CDx development by all sized drug companies have thus been growing rapidly in the recent years. It has been leading to the emerging of a new sector of the global pharmaceutical outsourcing industry.

Key Topics Covered:

Chapter One - Introduction

Chapter Two - Latest Trends of Biomarker Outsourcing

Chapter Three - Latest Trends of Companion Diagnostics Outsourcing

Chapter Four - Future Growth Potentials of Global Biomarker and Companion Diagnostics Outsourcing Market

For more information visit http://www.researchandmarkets.com/research/bfhs8p/global_biomarker

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Pharmaceuticals